InspireMD (NSPR) Receivables (2010 - 2025)

InspireMD's Receivables history runs 16 years deep, the most recent figure standing at $2.1 million for Q4 2025.

• On a quarterly basis, Receivables rose 38.33% year-over-year to $2.1 million in Q4 2025; TTM through Dec 2025 was $2.1 million, a 38.33% increase from a year earlier, with the FY2025 full-year figure at $2.6 million, up 13.93% from the prior year.
• Receivables declined to $2.1 million in Q4 2025 per NSPR's latest filing, from $2.4 million in the prior quarter.
• Across five years, Receivables topped out at $2.4 million in Q3 2025 and bottomed at $825000.0 in Q1 2021.
• The 5-year median for Receivables is $1.6 million (2024), against an average of $1.6 million.
• Across the five-year window, Receivables soared 300.0% in 2021 and slipped 27.57% in 2024, its largest moves.
• Year by year, Receivables stood at $1.2 million in 2021, then retreated by 16.67% to $1.0 million in 2022, then jumped by 100.87% to $2.1 million in 2023, then declined by 27.57% to $1.5 million in 2024, then soared by 38.33% to $2.1 million in 2025.
• Per Business Quant, the three latest NSPR Receivables figures stand at $2.1 million (Q4 2025), $2.4 million (Q3 2025), and $2.1 million (Q2 2025).